Previous close | 46.72 |
Open | 47.00 |
Bid | 46.66 x 100 |
Ask | 46.81 x 100 |
Day's range | 46.50 - 47.46 |
52-week range | 32.69 - 52.69 |
Volume | |
Avg. volume | 110,259 |
Market cap | 933.295M |
Beta (5Y monthly) | 0.71 |
PE ratio (TTM) | 89.81 |
EPS (TTM) | N/A |
Earnings date | N/A |
Forward dividend & yield | 0.24 (0.51%) |
Ex-dividend date | 26 Apr 2024 |
1y target est | N/A |
On May 1, 2024, Walter Woltosz, Director and 10% Owner of Simulations Plus Inc (NASDAQ:SLP), sold 20,000 shares of the company.
If we want to find a stock that could multiply over the long term, what are the underlying trends we should look for...
For the seventh consecutive year, the FDA has renewed Simulations Plus' (SLP) license to the DILIsym software system for facilitating drug safety evaluations.